The role of DNA methylation in aging, rejuvenation, and age-related disease

Rejuvenation Research

Volumn 15, Issue 5, 2012, Pages 483-494

  Johnson, Adiv A ^a   Akman, Kemal ^b   Calimport, Stuart R G ^c   Wuttke, Daniel ^d   Stolzing, Alexandra ^e   De Magalhães, João Pedro ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c ASTON UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; 5 METHYLCYTOSINE; AZACITIDINE; CISPLATIN; CYTOSINE; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; EPIGALLOCATECHIN GALLATE; HYDRALAZINE; MG 98; PLACEBO; S ADENOSYLMETHIONINE; TOPOTECAN; VALPROIC ACID; ZEBULARINE;

AGING; ARTICLE; CALORIC RESTRICTION; DEGENERATIVE DISEASE; DEMENTIA; DEMETHYLATION; DISEASE MARKER; DNA METHYLATION; EPIGENETICS; GENOME; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LONGEVITY; MOLECULAR MECHANICS; MYELODYSPLASTIC SYNDROME; NEOPLASM; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REJUVENATION; SOLID TUMOR; UTERINE CERVIX CANCER;

AGING; ANIMALS; DNA METHYLATION; DNA MODIFICATION METHYLASES; EPIGENESIS, GENETIC; HUMANS; REJUVENATION;

EID: 84868008258     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2012.1324     Document Type: Article

References (134)

1. Morgan HD, Santos F, Green K, Dean W, Reik W. Epige-netic reprogramming in mammals. Hum Mol Genet 2005;14(Spec No 1):R47-R58.
2. Okano M, Bell DW, Haber DA, Li E. DNA methyl-transferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999;99: 247-257.
3. Casadesús J, Low D. Epigenetic gene regulation in the bacterial world. Microbiol Mol Biol Rev 2006;70:830-856.
4. Zemach A, McDaniel IE, Silva P, Zilberman D. Genome-wide evolutionary analysis of eukaryotic DNA methyla-tion. Science 2010;328:916-919.
5. Bird AP, Wolffe AP. Methylation-induced repression\- belts, braces, and chromatin. Cell 1999;99:451-454.
6. Bogdanović O, Veenstra GJ. DNA methylation and methyl-CpG binding proteins: Developmental requirements and function. Chromosoma 2009;118:549-565.
7. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 2006;8:416-424.
8. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992;69:915-926.
9. Nguyen S, Meletis K, Fu D, Jhaveri S, Jaenisch R. Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened life-span. Dev Dyn 2007;236:1663-1676.
10. Ferguson-Smith AC Genomic imprinting: The emergence of an epigenetic paradigm. Nat Rev Genet 2011;12:565-575.
11. Basu R, Zhang LF. X chromosome inactivation: A silence that needs to be broken. Genesis 2011;49:821-834.
12. Sharp AJ, Stathaki E, Migliavacca E, Brahmachary M, Montgomery SB, Dupre Y, Antonarakis SE. DNA methyl-ation profiles of human active and inactive X chromo-somes. Genome Res 2011;21:1592-1600.
13. Richardson B. DNA methylation and autoimmune disease. Clin Immunol 2003;109:72-79.
14. Issa JP. Age-related epigenetic changes and the immune system. Clin Immunol 2003;109:103-108.
15. Sedivy JM, Banumathy G, Adams PD. Aging by epigenetics\- a consequence of chromatin damage? Exp Cell Res 2008; 314:1909-1917
16. Fraga MF, Agrelo R, Esteller M. Cross-talk between aging and cancer: The epigenetic language. Ann NY Acad Sci 2007;1100:60-74.
17. Kirkwood TB. Understanding the odd science of aging. Cell 2005; 120:437-447.
18. Zangi R, Arrieta A, Cossío FP. Mechanism of DNA meth-ylation: The double role of DNA as a substrate and as a cofactor. J Mol Biol 2010;400:632-644.
19. Fraga MF, Ballestar E, Montoya G, Taysavang P, Wade PA, Esteller M. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 2003;31:1765-1774.
20. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. Methylated DNA and MeCP2 recruit histone deacetylase to repress tran-scription. Nat Genet 1998;19:187-191.
21. Kokura K, Kaul SC, Wadhwa R, Nomura T, Khan MM, Shinagawa T, Yasukawa T, Colmenares C, Ishii S. The Ski protein family is required for MeCP2-mediated transcrip-tional repression. J Biol Chem 2001;276:34115-34121.
22. Wu SC, Zhang Y. Active DNA demethylation: Many roads lead to Rome. Nat Rev Mol Cell Biol 2010;11:607-620.
23. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011;333: 1300-1303.
24. Cortázar D, Kunz C, Selfridge J, Lettieri T, Saito Y, Mac-Dougall E, Wirz A, Schuermann D, Jacobs AL, Siegrist F, Steinacher R, Jiricny J, Bird A, Schär P. Embryonic lethal phenotype reveals a function of TDG in maintaining epi-genetic stability. Nature 2011;470:419-423.
25. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, Sun Y, Li X, Dai Q, Song CX, Zhang K, He C, Xu GL. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011; 333:1303-1307.
26. Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J, Barbera AJ, Zheng L, Zhang H, Huang S, Min J, Nicholson T, Chen T, Xu G, Shi Y, Zhang K, Shi YG. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 2011; 42:451-464.
27. Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA de-methylation in the adult brain. Cell 2011;145:423-434.
28. Williams K, Christensen J, Pedersen MT, Johansen JV, Cloos PA, Rappsilber J, Helin K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011; 473:343-348.
29. Qin W, Leonhardt H, Pichler G. Regulation of DNA me-thyltransferase 1 by interactions and modifications. Nu-cleus 2011;2:392-402.
30. Lee B, Muller MT. SUMOylation enhances DNA methyl-transferase 1 activity. Biochem J 2009;421:449-461.
31. Estève PO, Chang Y, Samaranayake M, Upadhyay AK, Horton JR, Feehery GR, Cheng X, Pradhan S. A methyla-tion and phosphorylation switch between an adjacent ly-sine and serine determines human DNMT1 stability. Nat Struct Mol Biol 2011;18:42-48.
32. Sugiyama Y, Hatano N, Sueyoshi N, Suetake I, Tajima S, Kinoshita E, Kinoshita-Kikuta E, Koike T, Kameshita I. The DNA-binding activity of mouse DNA methyltransferase 1 is regulated by phosphorylation with casein kinase 1delta/ epsilon. Biochem J 2010;427:489-497
33. Lund AH, van Lohuizen M. Polycomb complexes and si-lencing mechanisms. Curr Opin Cell Biol 2004;16:239-246.
34. Viré E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, Bollen M, Esteller M, Di Croce L, de Launoit Y, Fuks F. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006;439:871-874.
35. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suñer D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu Y-Z, Plass C, Esteller M. Epigenetic differences arise during the life-time of monozygotic twins. Proc Natl Acad Sci USA 2005;102:10604-10609.
36. Bocklandt S, Lin W, Sehl ME, Sánchez FJ, Sinsheimer JS, Horvath S, Vilain E. Epigenetic predictor of age. PLoS One 2011;6:e14821.
37. Langton AK, Herrick SE, Headon DJ. An extended epi-dermal response heals cutaneous wounds in the absence of a hair follicle stem cell contribution. J Invest Dermatol 2008;128:1311-1318.
38. Yan M, Zhang Z, Brady JR, Schilbach S, Fairbrother WJ, Dixit VM. Identification of a novel death domain-contain-ing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice. Curr Biol 2002;12:409-413.
39. Moran LB, Hickey L, Michael GJ, Derkacs M, Christian LM, Kalaitzakis ME, Pearce RK, Graeber MB. Neuronal pen-traxin II is highly upregulated in Parkinson's disease and a novel component of Lewy bodies. Acta Neuropathol 2008; 115:471-478.
40. Park JK, Ryu JK, Lee KH, Lee JK, Yoon WJ, Lee SH, Yoo JW, Woo SM, Lee GY, Lee CH, Kim YT, Yoon YB. Quan-titative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer. Pan-creas 2007;35:e9-e15.
41. Qi Y, Li X, Zhao L, Seykora JT. Decreased Srcasm expres-sion in esophageal squamous cell carcinoma in a Chinese population. Anticancer Res 2010;30:3535-3539.
42. Zhang W, Ji W, Yang J, Yang L, Chen W, Zhuang Z. Com-parison of global DNA methylation profiles in replicative versus premature senescence. Life Sci 2008;83:475-480.
43. Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science 1983;220:1055-1057.
44. Holliday R. Strong effects of 5-azacytidine on the in vitro lifespan of human diploid fibroblasts. Exp Cell Res 1986; 166:543-552.
45. So AY, Jung JW, Lee S, Kim HS, Kang KS. DNA methyl-transferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs. PLoS One 2011;6:e19503.
46. Bröske AM, Vockentanz L, Kharazi S, Huska MR, Mancini E, Scheller M, Kuhl C, Enns A, Prinz M, Jaenisch R, Nerlov C, Leutz A, Andrade-Navarro MA, Jacobsen SE, Ro-senbauer F. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet 2009;41:1207-1215.
47. Calvanese V, Fernández AF, Urdinguio RG, Suárez-Alvarez B, Mangas C, Pérez-García V, Bueno C, Montes R, Ramos-Mejía V, Martínez-Camblor P, Ferrero C, Assenov Y, Bock C, Menendez P, Carrera AC, Lopez-Larrea C, Fraga MF. A promoter DNA demethylation landscape of human hema-topoietic differentiation. Nucleic Acids Res 2011;40:116-131.
48. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448:313-317.
49. Romanov GA, Vanyushin BF. Methylation of reiterated sequences in mammalian DNAs. Effects of the tissue type, age, malignancy and hormonal induction. Biochim Biophys Acta 1981;653:204-218.
50. Vanyushin BF, Nemirovsky LE, Klimenko VV, Vasiliev VK, Belozersky AN. The 5-methylcytosine in DNA of rats. Tissue and age specificity and the changes induced by hydrocortisone and other agents. Gerontologia 1973;19: 138-152.
51. Singhal RP, Mays-Hoopes LL, Eichhorn GL. DNA meth-ylation in aging of mice. Mech Ageing Dev 1987;41: 199-210.
52. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Pad-bury JF, Bueno R, Sugarbaker DJ, Yeh R-F, Wiencke JK, Kelsey KT. Aging and environmental exposures alter tis-sue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009;5:e1000602.
53. Kwabi-Addo B, Chung W, Shen L, Ittmann M, Wheeler T, Jelinek J, Issa JP. Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res 2007;13: 3796-3802.
54. Bellizzi D, D'Aquila P, Montesanto A, Corsonello A, Mari V, Mazzei B, Lattanzio F, Passarino G. Global DNA methylation in old subjects is correlated with frailty. Age (Dordr) 2012;34:169-179.
55. Bollati V, Schwartz J, Wright R, Litonjua L, Tarantini L, Su H, Sparrow D, Vokonas P, Baccarelli A. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 2009;130:234-239.
56. Nikitin AG, Shmookler Reis RJ. Role of transposable ele-ments in age-related genomic instability. Genet Res 1997; 69:183-195.
57. Lutomska A, Lebedev A, Scharffetter-Kochanek K, Iben S. The transcriptional response to distinct growth factors is impaired in Werner syndrome cells. Exp Gerontol 2008;43:820-826.
58. Supić G, Kozomara R, Branković-Magić M, Jović N Magić Z. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Oral Oncol 2009;45: 1051-1057.
59. de Magalhães JP, Wuttke D, Wood SH, Plank M, Vora C. Genome-environment interactions that modulate aging: Powerful targets for drug discovery. Pharmacol Rev 2012; 64:88-101.
60. Joy TK, Arik AJ, Corby-Harris V, Johnson AA, Riehle MA. The impact of larval and adult dietary restriction on life-span, reproduction and growth in the mosquito Aedes ae-gypti. Exp Gerontol 2010;45:685-690.
61. Miller CA, Sweatt JD. Covalent modification of DNA reg-ulates memory formation. Neuron 2007;53:857-869.
62. Chouliaras L, van den Hove DL, Kenis G, Dela Cruz J, Lemmens MA, van Os J, Steinbusch HW, Schmitz C, Rutten BP. Caloric restriction attenuates age-related changes of DNA methyltransferase 3a in mouse hippocampus. Brain Behav Immun 2011;25:616-623.
63. Chouliaras L, van den Hove DL, Kenis G, Keitel S, Hof PR, van Os J, Steinbusch HW, Schmitz C, Rutten BP. Preven-tion of age-related changes in hippocampal levels of 5-methylcytidine by caloric restriction. Neurobiol Aging 2012;33:1672-1681.
64. Chouliaras L, van den Hove DL, Kenis G, Keitel S, Hof PR, van Os J, Steinbusch HW, Schmitz C, Rutten BP. Age-related increase in levels of 5-hydroxymethylcytosine in mouse hippocampus is prevented by caloric restriction. Curr Alzheimer Res 2012;9:536-544.
65. Lin MJ, Tang LY, Reddy MN, Shen CK. DNA methyl-transferase gene dDnmt2 and longevity of Drosophila. J Biol Chem 2005;280:861-864.
66. Lyko F, Foret S, Kucharski R, Wolf S, Falckenhayn C, Maleszka R The honey bee epigenomes: differential methylation of brain DNA in queens and workers. PLoS Biol 2010;8:e1000506.
67. Kucharski R, Maleszka J, Foret S, Maleszka R Nutritional control of reproductive status in honeybees via DNA methylation. Science 2008;319:1827-1830.
68. Ahuja N, Issa JP. Aging, methylation and cancer. Histol Histopathol 2000;15:835-842.
69. Peters I, Vaske B, Albrecht K, Kuczyk MA, Jonas U, Serth J. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue. Cancer Epidemiol Bio-markers Prev 2007;16:2526-2532.
70. Euhus DM, Bu D, Milchgrub S, Xie XJ, Bian A, Leitch AM, Lewis CM. DNA methylation in benign breast epithelium in relation to age and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008;17:1051-1059.
71. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:536-540.
72. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, Milliken EE, Issa JP. Me-thylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999;43:985-991.
73. Li LC, Shiina H, Deguchi M, Zhao H, Okino ST, Kane CJ, Carroll PR, Igawa M, Dahiya R. Age-dependent methyla-tion of ESR1 gene in prostate cancer. Biochem Biophys Res Commun 2004;321:455-461.
74. Mikol YB, Hoover KL, Creasia D, Poirier LA. Hepato-carcinogenesis in rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 1983;4:1619-1629.
75. Pogribny IP, Ross SA, Wise C, Pogribna M, Jones EA, Tryndyak VP, James SJ, Dragan YP, Poirier LA. Irreversible global DNA hypomethylation as a key step in hepato-carcinogenesis induced by dietary methyl deficiency. Mutat Res 2006;593:80-87.
76. Zhou W, Alonso S, Takai D, Lu SC, Yamamoto F, Perucho M, Huang S. Requirement of RIZ1 for cancer prevention by methyl-balanced diet. PLoS One 2008;3:e3390.
77. Shah MY, Licht JD. DNMT3A mutations in acute myeloid leukemia. Nat Genet 2011;43:289-290.
78. Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M, Fulton R, Schmidt H, Kalicki-Veizer J, O'Laughlin M, Kandoth C, Baty J, Westervelt P, DiPersio JF, Mardis ER, Wilson RK, Ley TJ, Graubert TA. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011;25:1153-1158.
79. Gao Q, Steine EJ, Barrasa MI, Hockemeyer D, Pawlak M, Fu D, Reddy S, Bell GW, Jaenisch R Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression. Proc Natl Acad Sci USA 2011;108:18061-18066.
80. Belinsky SA. Gene-promoter hypermethylation as a bio-marker in lung cancer. Nat Rev Cancer 2004;4:707-717
81. Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing Jr. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 2003;17:637-641.
82. Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Massé A, Kosmider O, Le Couedic JP, Robert F, Alberdi A, Lécluse Y, Plo I, Dreyfus FJ, Marzac C, Casadevall N, Lacombe C, Romana SP, Dessen P, Soulier J, Viguié F, Fontenay M, Vainchenker W, Bernard OA. Mutations in TET2 in myeloid cancers. N Engl J Med 2009;360: 2289-2301.
83. Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, Toubaji A, Argani P, Iacobuzio-Donahue C, Nelson WG, Netto GJ, De Marzo AM, Yegnasubramanian S. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011;2:627-637.
84. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009; 462:739-744.
85. Prensner JR, Chinnaiyan AM. Metabolism unhinged: IDH mutations in cancer. Nat Med 2011;17:291-293.
86. Silva PN, Gigek CO, Leal MF, Bertolucci PH, de Labio RW, Payão SL, Smith MeA. Promoter methylation anal-ysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease. J Alzheimers Dis 2008;13: 173-176.
87. Bollati V, Galimberti D, Pergoli L, Dalla Valle E, Barretta F, Cortini F, Scarpini E, Bertazzi PA, Baccarelli A. DNA methylation in repetitive elements and Alzheimer disease. Brain Behav Immun 2011;25:1078-1083.
88. Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethio-nine levels are severely decreased in Alzheimer's disease. J Neurochem 1996;67:1328-1331.
89. Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One 2009;4:e6617.
90. van den Hove DL, Chouliaras L, Rutten BP. The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: Current status and prospects for future studies. Curr Alz-heimer Res 2012;9:545-549.
91. Morgan AR, Hamilton G, Turic D, Jehu L, Harold D, Abraham R, Hollingworth P, Moskvina V, Brayne C, Ru-binsztein DC, Lynch A, Lawlor B, Gill M, O'Donovan M, Powell J, Lovestone S, Williams J, Owen MJ. Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2008;147B:727-731.
92. Coppedè F, Zitarosa MT, Migheli F, Lo Gerfo A, Bagnoli S, Dardano A, Nacmias B, Mancuso M, Monzani F, Siciliano G, Sorbi S, Migliore L. DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. Curr Alzheimer Res 2012;9:550-554.
93. Matsumoto L, Takuma H, Tamaoka A, Kurisaki H, Date H, Tsuji S, Iwata A. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Par-kinson's disease. PLoS One 2010;5:e15522.
94. Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S, Hojo K, Yamanishi H, Karpf AR, Wallace DC, Simon M, Lander C, Boardman LA, Cunningham JM, Smith GE, Litchy WJ, Boes B, Atkinson EJ, Middha S, B Dyck PJ, Parisi JE, Mer G, Smith DI, Dyck PJ. Mutations in DNMT1 cause hereditary sensory neuropathy with de-mentia and hearing loss. Nat Genet 2011;43:595-600.
95. Loeser RF, Im HJ, Richardson B, Lu Q, Chubinskaya S. Methylation of the OP-1 promoter: Potential role in the age-related decline in OP-1 expression in cartilage. Osteoar-thritis Cartilage 2009;17:513-517
96. Liu ZH, Chen LL, Deng XL, Song HJ, Liao YF, Zeng TS, Zheng J, Li HQ. Methylation status of CpG Sites in the MCP-1 promoter is correlated to serum MCP-1 in type 2 diabetes. J Endocrinol Invest 2012;6:585-589.
97. Sapienza C, Lee J, Powell J, Erinle O, Yafai F, Reichert J, Siraj ES, Madaio M. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics 2011;6:20-28.
98. Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 2008;266:6-11.
99. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nat-ure 2004;429:457-463.
100. Mack GS. To selectivity and beyond. Nat Biotechnol 2010; 28:1259-1266.
101. Sullivan M, Hahn K, Kolesar JM. Azacitidine: A novel agent for myelodysplastic syndromes. Am J Health Syst Pharm 2005;62:1567-1573.
102. Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J, Klimek V, Slack J, de Castro C, Ravandi F, Helmer R 3rd, Shen L, Nimer SD, Leavitt R, Raza A, Saba H. Decitabine improves patient outcomes in myelodys-plastic syndromes: Results of a phase III randomized study. Cancer 2006;106:1794-1803.
103. Scott SA, Dong WF, Ichinohasama R, Hirsch C, Sheridan D, Sanche SE, Geyer CR, Decoteau JF. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation. Leuk Res 2006;30: 69-76.
104. Uenogawa K, Hatta Y, Arima N, Hayakawa S, Sawada U, Aizawa S, Yamamoto T, Takeuchi J. Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma. Int J Mol Med 2011;28: 835-839.
105. Villar-Garea A, Fraga MF, Espada J, Esteller M. Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res 2003;63:4984-4989.
106. Segura-Pacheco B, Trejo-Becerril C, Perez-Cardenas E, Taja-Chayeb L, Mariscal I, Chavez A, Acuña C, Salazar AM, Lizano M, Dueñas-Gonzalez A. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Clin Cancer Res 2003;9:1596-1603.
107. Lee BH, Yegnasubramanian S, Lin X, Nelson WG. Procai-namide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem 2005;280:40749-40756.
108. Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, Ri-chardson B. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 2003;48:746-756.
109. Zambrano P, Segura-Pacheco B, Perez-Cardenas E, Cetina L, Revilla-Vazquez A, Taja-Chayeb L, Chavez-Blanco A, Angeles E, Cabrera G, Sandoval K, Trejo-Becerril C, Cha-nona-Vilchis J, Duenas-González A. A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer 2005;5:44.
110. Coronel J, Cetina L, Pacheco I, Trejo-Becerril C, González-Fierro A, de la Cruz-Hernandez E, Perez-Cardenas E, Taja-Chayeb L, Arias-Bofill D, Candelaria M, Vidal S, Dueñas-González A. A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results. Med Oncol 2011;Suppl 1:S540-546.
111. Park LK, Friso S, Choi SW. Nutritional influences on epige-netics and age-related disease. Proc Nutr Soc 2012;71:75-83.
112. Locker J, Reddy TV, Lombardi B. DNA methylation and hepatocarcinogenesis in rats fed a choline-devoid diet. Carcinogenesis 1986;7:1309-1312.
113. Miller RA, Buehner G, Chang Y, Harper JM, Sigler R, Smith-Wheelock M. Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glu-cose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell 2005;4:119-125.
114. Troen AM, French EE, Roberts JF, Selhub J, Ordovas JM, Parnell LD, Lai CQ. Lifespan modification by glucose and methionine in Drosophila melanogaster fed a chemically defined diet. Age (Dordr) 2007;29:29-39.
115. Richie JP, Leutzinger Y, Parthasarathy S, Malloy V, Oren-treich N, Zimmerman JA. Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J 1994;8:1302-1307
116. Komninou D, Leutzinger Y, Reddy BS, Richie JP. Methio-nine restriction inhibits colon carcinogenesis. Nutr Cancer 2006;54:202-208.
117. Sanchez-Roman I, Gomez A, Gomez J, Suarez H, Sanchez C, Naudi A, Ayala V, Portero-Otin M, Lopez-Torres M, Pamplona R, Barja G. Forty percent methionine restriction lowers DNA methylation, complex I ROS generation, and oxidative damage to mtDNA and mitochondrial proteins in rat heart. J Bioenerg Biomembr 2011;43:699-708.
118. Batra V, Sridhar S, Devasagayam TP. Enhanced one-carbon flux towards DNA methylation: Effect of dietary methyl supplements against gamma-radiation- induced epigenetic modifications. Chem Biol Interact 2010;183:425-433.
119. Nandakumar V, Vaid M, Katiyar SK. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011;32:537-544.
120. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. Tea polyphenol (-)-epigallocatechin-3-gallate in-hibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003;63:7563-7570.
121. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other iso-flavones from soy. Clin Cancer Res 2005;11(19 Pt 1):7033-7041.
122. Fritz WA, Coward L, Wang J, Lamartiniere CA. Dietary genistein: Perinatal mammary cancer prevention, bioavail-ability and toxicity testing in the rat. Carcinogenesis 1998; 19:2151-2158.
123. Amato RJ. Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy. Clin Genitourin Cancer 2007;5:422-426.
124. Plummer R, Vidal L, Griffin M, Lesley M, de Bono J, Coulthard S, Sludden J, Siu LL, Chen EX, Oza AM, Reid GK, McLeod AR, Besterman JM, Lee C, Judson I, Calvert H, Boddy AV. Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors. Clin Cancer Res 2009;15:3177-3183.
125. Winquist E, Knox J, Ayoub JP, Wood L, Wainman N, Reid GK, Pearce L, Shah A, Eisenhauer E. Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonu-cleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study. Invest New Drugs 2006;24:159-167.
126. Leu YW, Rahmatpanah F, Shi H, Wei SH, Liu JC, Yan PS, Huang TH. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactiva-tion. Cancer Res 2003;63:6110-6115.
127. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011;29:341-345.
128. Castanotto D. Sensor and sensitivity: A screen for elite shRNAs. Mol Ther 2011;19:823--825.
129. Castanotto D, Rossi JJ. The promises and pitfalls of RNA-interference- based therapeutics. Nature 2009;457:426-433.
130. de Magalhães JP, Finch CE, Janssens G. Next-generation sequencing in aging research: Emerging applications, problems, pitfalls and possible solutions. Ageing Res Rev 2010;9:315-323.
131. Cox LS, Mason PA Prospects for rejuvenation of aged tissue by telomerase reactivation. Rejuvenation Res 2010;13:749-754.
132. Obrenovich ME, Nair NG, Beyaz A, Aliev G, Reddy VP. The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res 2010;13:631-643.
133. Best BP. Nuclear DNA damage as a direct cause of aging. Rejuvenation Res 2009;12:199-208.
134. Dubec SJ, Aurora R, Zassenhaus HP. Mitochondrial DNA mutations may contribute to aging via cell death caused by peptides that induce cytochrome c release. Rejuvenation Res 2008;11:611-619.